Goli gummies are not FDA approved, and they never will be, because the FDA does not approve dietary supplements. This is not a red flag specific to Goli. No supplement on the market, from any brand, carries FDA approval. The distinction matters because it shapes what you can and can’t expect in terms of safety oversight.
Why the FDA Doesn’t Approve Supplements
The FDA regulates dietary supplements as food, not as drugs. That single legal classification changes everything. Prescription and over-the-counter drugs must go through a rigorous, years-long approval process where the manufacturer proves the product is both safe and effective before it ever reaches a pharmacy shelf. Supplements skip that entire process.
Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplements can go to market without proving they work. The FDA only steps in after the fact, if a product turns out to be unsafe or if a company makes illegal health claims. Think of it as the difference between a bouncer checking IDs at the door (drugs) versus security cameras that review footage after something goes wrong (supplements).
This means when you see any supplement brand advertising itself as “FDA approved,” that’s a misleading claim. The correct language is “FDA regulated,” and even that requires some context.
What FDA Oversight Goli Actually Has
While Goli gummies aren’t approved by the FDA, they aren’t completely unregulated either. Several layers of oversight do apply.
Goli products are manufactured in the United States in facilities that follow Current Good Manufacturing Practices (cGMP). These are FDA-enforced standards that govern how supplements are produced, tested, and packaged. A cGMP-compliant facility must control for contamination, verify ingredient identity and potency, and keep detailed production records. The FDA can inspect these facilities and issue warning letters or shut them down if standards aren’t met.
Goli is also required to report any serious adverse events to the FDA. And the company cannot legally claim its gummies treat, cure, or prevent any disease. Supplement labels are required to carry a disclaimer stating that the product’s claims have not been evaluated by the FDA. If you flip over a bottle of Goli gummies, you’ll find that standard disclaimer on the back.
The Difference Between “Approved” and “Safe”
Lack of FDA approval does not automatically mean a product is unsafe. It means the product hasn’t been through the specific clinical trial process required for drugs. Many supplement ingredients, including the vitamins, pectin, and apple cider vinegar found in Goli products, have long histories of use and are generally recognized as safe in the amounts typically consumed.
That said, the lack of pre-market review does leave a gap. Without FDA approval, you’re relying on the manufacturer’s own quality controls and third-party testing rather than government-verified clinical data. This is true for every supplement, not just Goli. The practical takeaway: cGMP compliance and third-party certifications are the closest things to quality assurance you’ll find in the supplement world, and Goli does check the cGMP box.
How to Evaluate Supplement Quality Without FDA Approval
Since the FDA won’t do pre-market vetting for you, a few signals help separate reputable brands from questionable ones:
- cGMP-compliant manufacturing: This confirms the facility meets FDA production standards. Goli manufactures in cGMP facilities in the U.S.
- Third-party testing: Independent labs like NSF International, USP, or ConsumerLab verify that what’s on the label is actually in the bottle. Look for certification seals on the packaging.
- No disease claims: Legitimate supplement companies don’t claim their products cure or treat specific diseases. If a brand says its gummy cures diabetes, walk away.
- Transparent ingredient lists: You should be able to see every active and inactive ingredient, along with exact amounts, on the Supplement Facts panel.
What’s Changing in Supplement Regulation
The FDA has been signaling tighter oversight of the supplement industry. In June 2025, the agency released new educational materials on the notification process companies must follow when using novel dietary ingredients. A public meeting on the scope of dietary ingredients is scheduled for March 2026. These steps suggest the regulatory gap between supplements and drugs may narrow somewhat in the coming years, potentially requiring brands like Goli to provide more documentation about their ingredients before selling products.
For now, though, the fundamental framework hasn’t changed. Supplements remain regulated as food, and no gummy, capsule, or powder from any company carries FDA approval.